Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80.7M
-
Number of holders
-
173
-
Total 13F shares, excl. options
-
38.1M
-
Shares change
-
-2.32M
-
Total reported value, excl. options
-
$191M
-
Value change
-
-$15.4M
-
Put/Call ratio
-
0.85
-
Number of buys
-
78
-
Number of sells
-
-80
-
Price
-
$5.00
Significant Holders of Altimmune, Inc. - Common Stock (ALT) as of Q1 2025
229 filings reported holding ALT - Altimmune, Inc. - Common Stock as of Q1 2025.
Altimmune, Inc. - Common Stock (ALT) has 173 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38.1M shares
of 80.7M outstanding shares and own 47.25% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (6.14M shares), VANGUARD GROUP INC (4.41M shares), STATE STREET CORP (3.39M shares), TANG CAPITAL MANAGEMENT LLC (2.75M shares), GEODE CAPITAL MANAGEMENT, LLC (1.71M shares), AMERIPRISE FINANCIAL INC (1.44M shares), MARSHALL WACE, LLP (1.17M shares), TWO SIGMA INVESTMENTS, LP (1.15M shares), Knoll Capital Management, LLC (1.12M shares), and MILLENNIUM MANAGEMENT LLC (1.11M shares).
This table shows the top 173 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.